A Multicenter, Double-Blind, Randomized, Crossover, Single-Dose Study With An Open-Label Treatment Period Evaluating Pharmacodynamic Activity of E2082 in Adult Subjects With Photosensitive Epilepsy
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2019
Price : $35 *
At a glance
- Drugs E-2082 (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 02 Dec 2019 Status changed from suspended to completed.
- 25 Jul 2019 Planned End Date changed from 15 Aug 2019 to 18 Nov 2019.
- 25 Jul 2019 Planned primary completion date changed from 15 Aug 2019 to 18 Nov 2019.